SPORT High-Risk Trial Evaluating SABR in Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 18, 2016

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Prostate Cancer
Interventions
RADIATION

Stereotatic Radiotherapy

SABR to prostate / seminal nodes

Trial Locations (1)

BT9 7AB

Belfast Health and Social Care Trust, Belfast

All Listed Sponsors
lead

Belfast Health and Social Care Trust

OTHER

NCT03253978 - SPORT High-Risk Trial Evaluating SABR in Prostate Cancer | Biotech Hunter | Biotech Hunter